Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2
Targeting the main protease of SARS-CoV-2Inside host cells, the RNA genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is translated into two polyproteins that are cleaved to yield the individual viral proteins. The main…